Scientific publications


Koningstein M, van der Bij AK, de Kraker ME, Monen JC, Muilwijk J, de Greeff SC, Geerlings SE, van Hall MA; ISIS-AR Study Group

Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands 

PLoS One. 2014 Jan 28;9(1):e86634. doi: 10.1371/journal.pone.0086634. eCollection 2014. PubMed PMID: 24489755; PubMed Central PMCID: PMC3904917


Houben AJ, Oostdijk EA, van der Voort PH, Monen JC, Bonten MJ, van der Bij AK; ISIS-AR Study Group

Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands 

J Antimicrob Chemother. 2014 Mar;69(3):797-804. doi: 10.1093/jac/dkt416. Epub 2013 Oct 21. PubMed PMID: 24144922


Leverstein-van Hall MA, Waar K, Muilwijk J, Cohen Stuart J; ISIS-AR Study Group

Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli. 

J Antimicrob Chemother. 2013 Nov;68(11):2636-40. doi: 10.1093/jac/dkt218. Epub 2013 Jun 13. PubMed PMID: 23766488


van der Bij AK, van Dijk K, Muilwijk J, Thijsen SF, Notermans DW, de Greeff S, van de Sande-Bruinsma N; ISIS-AR study group

Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia 

Clin Microbiol Infect. 2012 Nov;18(11):E466-72. doi: 10.1111/j.1469-0691.2012.03996.x. Epub 2012 Aug 27. PubMed PMID: 22925456

RIVM Committed to health and sustainability